According to Bodycote's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 1866. At the end of 2022 the company had a P/E ratio of 15.3.
Year | P/E ratio | Change |
---|---|---|
2022 | 15.3 | -41.14% |
2021 | 25.9 | -99.25% |
2020 | > 1000 | 18587.83% |
2019 | 18.6 | 43.1% |
2018 | 13.0 | -21.81% |
2017 | 16.6 | -10.6% |
2016 | 18.6 | 14.01% |
2015 | 16.3 | 29.89% |
2014 | 12.6 | -4.03% |
2013 | 13.1 | 27.66% |
2012 | 10.3 | 44.6% |
2011 | 7.10 | -53.66% |
2010 | 15.3 | -428.66% |
2009 | -4.66 | -321.5% |
2008 | 2.10 | -70.83% |
2007 | 7.21 | -33.82% |
2006 | 10.9 | -14.71% |
2005 | 12.8 | 12.93% |
2004 | 11.3 | -140.26% |
2003 | -28.1 | -179.21% |
2002 | 35.5 | 138.53% |
2001 | 14.9 |
The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.
Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.